Related Experiment Videos

Vascular changes of methotrexate-related disseminated necrotizing leukoencephalopathy

Acta Neuropathologica
|January 1, 1984
PubMed

Insights

Methotrexate (MTX) causes disseminated necrotizing leukoencephalopathy (DNL) by damaging small veins and capillaries in leukemia patients. This vascular injury is linked to direct, prolonged effects of intrathecal MTX.

Area of Science:

  • Neuropathology
  • Toxicology
  • Oncology

Background:

  • Investigating methotrexate (MTX)-related disseminated necrotizing leukoencephalopathy (DNL) in leukemia patients.
  • Utilizing advanced reconstruction techniques for detailed analysis of cerebral lesions.

Observation:

  • Examined autopsy cases of leukemia with DNL using serial and thick section reconstruction.
  • Silver impregnation highlighted topographic relationships between vascular changes and parenchymal lesions.

Findings:

  • Observed fibrinoid degeneration, vascular wall thickening, and lumen changes in venules and capillaries, particularly on the venous side.
  • Parenchymal lesions, including necrotic foci, were topographically associated with these specific vascular alterations.
  • Arteries showed minimal changes, with only moderate endothelial swelling in arteriolar capillaries.

Implications:

  • Suggests DNL in leukemia patients stems from damage to venules and capillaries, likely due to direct, prolonged intrathecal MTX exposure.
  • Highlights the critical role of venous-side microvasculature in MTX-induced neurotoxicity.
  • Provides insights into the pathogenesis of MTX-related leukoencephalopathy.

Related Concept Videos